Table 2.
Response | Ondansetron; Arm 1; n = 47; No. (%) | Palonosetron | P | |
---|---|---|---|---|
Arm 2; Days 1–5; n = 48; No. (%) | Arm 3; Days 1, 3, 5; n = 48; No. (%) | |||
Response | 16 (34) | 22 (46) | 21 (44) | .46 |
Complete response | 10 (21) | 15 (31) | 17 (35) | |
Partial response | 6 (13) | 7 (15) | 4 (8) | |
Failure | 31 (67) | 26 (54) | 27 (56) | .32 |